gastric cancer

Bristol Myers’ Opdivo Receives FDA Approval for Gastric Cancer
BioSpace
Mon, 04/19/21 - 10:32 pm
Bristol Myers Squibb
FDA
gastric cancer
Opdivo
Amgen adds gastric cancer drug candidate in $1.9 billion Five Prime Therapeutics deal
Reuters
Thu, 03/4/21 - 10:29 am
Amgen
Five Prime Therapeutics
M&A
gastric cancer
Enhertu picks up another win for AstraZeneca and Daiichi Sankyo, joining the priority review lane for gastric cancer
Endpoints
Wed, 10/28/20 - 10:32 am
AstraZeneca
Daiichi Sankyo
Enhertu
breakthrough status
FDA
metastatic gastric cancer
gastric cancer
FDA fast-tracks Leap’s gastric cancer immunotherapy
Pharmaforum
Fri, 09/25/20 - 10:34 am
Leap Therapeutics
FDA
DKN-01
priority review
gastric cancer
Bristol Myers Squibb’s Opdivo Hits Mark in Two Phase III Studies
BioSpace
Wed, 08/12/20 - 12:31 am
Bristol-Myers Squibb
Opdivo
clinical trials
gastric cancer
esophageal cancer
Pieris begins gastric cancer combination trial with Lilly’s Cyramza
Pharmaforum
Tue, 08/11/20 - 11:41 am
Pieris
Eli Lilly
PRS-343
Cyramza
gastric cancer
clinical trial
AstraZeneca to unveil key data for cancer drugs at ASCO
Pharmaforum
Fri, 05/15/20 - 10:41 am
AstraZeneca
ASCO 2020
Tagrisso
lung cancer
Enhertu
breast cancer
gastric cancer
colorectal cancer
AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug
Pharmaceutical Business Review
Mon, 05/11/20 - 10:27 am
AstraZeneca
Daiichi Sankyo
FDA
Enhertu
gastric cancer
breakthrough therapy
Macrogenics scoops its ASCO bounce
EP Vantage
Fri, 05/8/20 - 10:20 am
ASCO 2020
Macrogenics
margetuximab
cancer
breast cancer
gastric cancer
After $105M funding round, ALX Oncology nabs FDA fast-track tag for cancer hopeful
Fierce Biotech
Tue, 02/18/20 - 10:55 am
ALX Oncology
fast rack
FDA
head and neck cancer
ALX148
gastric cancer
Breast cancer approval in tow, AstraZeneca, Daiichi armed antibody scores in key gastric cancer study
Endpoints
Mon, 01/27/20 - 10:44 am
AstraZeneca
breast cancer
Daiichi Sankyo
trastuzumab deruxtecan
gastric cancer
FDA grants breakthrough status to AI-based gastric cancer diagnostic
Medtech Dive
Tue, 11/12/19 - 08:11 pm
gastric cancer
AI Medical Service
diagnostics
FDA
artificial intelligence
devices
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Marketwatch
Fri, 11/8/19 - 10:45 am
Merck KGaA
Pfizer
Bavencio
clinical trials
gastric cancer
Leap zeroes in on subgroup for DKN-01, Keytruda combo
BioCentury
Wed, 08/7/19 - 11:32 pm
Leap Therapeutics
DKN-01
Keytruda
gastric cancer
Keytruda PhIII failure in gastric cancer blights Merck's quest for frontline dominance
Endpoints
Fri, 04/26/19 - 10:14 am
Merck
Keytruda
gastric cancer
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
CP Wire
Mon, 10/1/18 - 09:38 am
Five Prime
Zai Lab
bemarituzumab
gastric cancer
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
Mon, 10/1/18 - 09:38 am
Five Prime
Zai Lab
bemarituzumab
gastric cancer
Immunicum AB Announces FDA Approval to Expand Ph Ib/II trial of Cancer Drug
CP Wire
Mon, 07/23/18 - 10:12 am
Immunicum
clinical trials
ilixadencel
head and neck cancer
non-small cell lung cancer
gastric cancer
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
CP Wire
Thu, 06/21/18 - 10:13 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
Thu, 06/21/18 - 09:53 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer

Pages